Healix

What Healix does

Healix is a US-based outpatient infusion management platform founded in 1989 and headquartered in Sugar Land, Texas, operating 220+ (with the company's About Us page citing 230+) physician-owned and ambulatory infusion centers across 38 states. The company specializes in therapeutic areas including infectious disease, gastroenterology, neurology, rheumatology, allergy, immunology, and pulmonology, delivering care in physician office and ambulatory settings as an alternative to hospital-based infusion.

The platform is built around six integrated service lines: infusion management services (drug procurement, revenue cycle management, nursing and pharmacy staffing); Healix Infusion Care, a company-managed ambulatory infusion center network; ACHC-accredited 503A pharmacy services with USP <797> and <800> compliant sterile compounding; NABP-accredited wholesale distribution from a 20,000 sq ft facility handling 60 NDCs; clinical outcomes research leveraging what Healix describes as the largest data warehouse in the outpatient infusion industry; and outsourced patient support and hub services (benefits verification, prior authorization, appeals, copay support) for pharmaceutical manufacturers. Underlying technology includes proprietary infusion management software, real-time financial and KPI reporting, and blockchain-enabled supply chain traceability.

Healix generates revenue through a mix of managed-services fees, drug margin on procured and infused medications, wholesale distribution fees, professional services for manufacturer hub programs, and collaborative research arrangements with pharmaceutical companies such as Ferring Pharmaceuticals and Melinta Therapeutics. The company sells primarily through direct enterprise partnerships with physician practices, hospital systems, and ambulatory infusion centers, supported by Client Services Executives and active participation at industry conferences across multiple specialties. In June 2026, Healix was acquired by Singlepoint Healthcare, a DFW Capital Partners-backed platform, becoming Singlepoint's third specialty infusion acquisition in roughly a year alongside The Boster Center for Multiple Sclerosis and IV Solutions.

Name

Healix

Legal name

Healix

Website

https://healix.net

Company type

Private

Founded year

1989

Operating status

Acquired

Headcount range

251–500 employees

Short description

Healix is a US outpatient infusion management platform operating 220+ physician-owned and ambulatory infusion centers across 38 states, offering infusion management, pharmacy, wholesale distribution, manufacturer hub services, and clinical outcomes research in infectious disease, gastroenterology, neurology, rheumatology, allergy, immunology, and pulmonology.

Ownership category

akta.pro rank

Product category

Outpatient Infusion Management Services

NAICS

Outpatient Care Centers (6214), Other Ambulatory Health Care Services (6219), Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Infusion Therapy Centers (Outpatient) (HLAFABAF)

akta.pro secondary industries

Infusion & Home Infusion Pharmacy Services (HLAFALAG), Home Infusion Therapy Providers (HLAFAEAE), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Outpatient infusion management
• Ambulatory infusion centers
• Specialty pharmacy services
• Pharmaceutical wholesale distribution
• Clinical outcomes research

Headquarters

HQ city

Sugar Land

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Infusion Center Management Services: Comprehensive management services for physician-owned and ambulatory infusion centers including drug procurement, revenue cycle management, managed care programs, and clinical staffing. Revenue generated through operational fees and drug margin on infused medications.
2. Pharmacy Services: Accredited pharmacy offering patient-specific injectable and infusion medications, sterile compounding, and clinical pharmacy services 24/7 to hospital systems, institutions, and outpatient facilities nationwide.
3. Wholesale Distribution: Pharmaceutical distribution services spanning 60 National Drug Codes (NDCs) across 38 states through a 20,000 sq ft distribution center. Revenue from distribution fees and drug margin.
4. Hub/Patient Support Services: Outsourced patient support services for pharmaceutical manufacturers including benefits verification, prior authorization, appeals facilitation, and copay support services.
5. Clinical Outcomes Research: Collaborative research with manufacturers and physicians to study novel therapies, compare treatment sites, and conduct cutting-edge research using Healix's extensive data warehouse.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Healix provides comprehensive outpatient infusion management services to physician practices, hospital systems, and pharmaceutical manufacturers, including drug procurement, revenue cycle management, managed care programs, clinical staffing, and on-site pharmacy support. The company operates a network of more than 220 physician-owned and ambulatory infusion centers across the United States, an ACHC-accredited 503A sterile compounding pharmacy in Sugar Land, Texas, and a wholesale pharmaceutical distribution network spanning 38 states with 60 National Drug Codes. Additional offerings include outsourced patient support/hub services for manufacturers and clinical outcomes research powered by what Healix describes as the largest data warehouse in the outpatient infusion industry.

Product overview

Healix is a comprehensive outpatient infusion management platform offering six interconnected service lines: Infusion Management Services (physician office-based management with drug procurement, revenue cycle, nursing, and pharmacy components), Ambulatory Infusion Centers (Healix-owned clinic network), Pharmacy Services (ACHC-accredited 503A sterile compounding pharmacy), Wholesale Distribution (pharmaceutical distribution with 60 NDCs across 38 states), Clinical Outcomes Research (data warehouse and real-world evidence studies), and Outsourced Patient Support and Hub Services (manufacturer patient access services). The company operates over 230 infusion centers nationwide, specializing in infectious disease, gastroenterology, neurology, rheumatology, allergy, immunology, and pulmonology. Sub-products include Drug Procurement Services, Revenue Cycle Services, Core Infusion Services, Nursing Infusion Services, and Pharmacy Infusion Services.

Differentiator

Problem solved

Functional benefit

Products and services

• Infusion Management Services Physician office-based infusion management services providing drug procurement, revenue cycle management, managed care programs, and clinical staffing to help healthcare providers deliver infusion therapies in outpatient settings.
• Ambulatory Infusion Centers (Healix Infusion Care)

Quantifiable outcome

• Significant cost savings demonstrated in outpatient treatment vs. hospital settings for conditions including MRSA infections, septicemia, and skin infections
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered minor and core.

• AlertMediaminorStrategic or Co-development Partner · 23 March 2026AlertMedia partners with Healix to provide a comprehensive global travel risk management solution. The partnership delivers end-to-end global travel risk management for organizations with international operations or travelers.
• Ferring PharmaceuticalscoreStrategic or Co-development PartnerHealix collaborates with Ferring Pharmaceuticals on clinical research, including studies on fecal microbiota live-jslm for the prevention of recurrent Clostridioides difficile infection presented at ACG 2025.
• Melinta TherapeuticscoreStrategic or Co-development PartnerHealix collaborates with Melinta Therapeutics on clinical studies including real-world experience with Rezafungin, a novel long-acting echinocandin, presented at ESCMID Global 2025.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Soleo Health: Specialty infusion services company offering home and alternate-site infusion therapies, specialty pharmacy, and clinical management - directly comparable to Healix's physician office management and ambulatory infusion center offerings.
• Vital Care Infusion Services: Franchise network of ambulatory infusion centers providing outpatient infusion services to physician practices, directly competing with Healix's physician office management and AIC service lines across multiple states.
• Amerita: Specialty infusion and home infusion pharmacy provider (KKR-backed) serving patients with chronic and complex conditions; competes with Healix across home/site-of-care infusion delivery.
• BioMatrix Specialty Pharmacy: Specialty pharmacy focused on infused and injectable therapies for chronic conditions including autoimmune disorders, offering home infusion and patient support services that overlap with Healix's pharmacy and hub services lines.
• Option Care Health: Largest independent provider of home and alternate-site infusion services in the US, with a national footprint and broad specialty infusion capabilities overlapping directly with Healix's physician office and ambulatory infusion center model.
• IV Solutions: Provider of outpatient infusion services now operating as a sister company to Healix within Singlepoint Healthcare, sharing the same specialty infusion and chronic disease focus.

Emerging players

• ContinuumRx: Specialty infusion services provider focused on hospital-system joint ventures for outpatient infusion, overlapping with Healix's institutional pharmacy and ambulatory infusion offerings.

Broad incumbents

• Coram (CVS Health): CVS Health's home infusion and specialty pharmacy arm; offers overlapping infusion services at much greater scale and with vertically integrated payer (Caremark) and retail capabilities.
• Walgreens Specialty Pharmacy: Large retail-backed specialty pharmacy providing infusion, injectable therapy management, and hub services that compete with Healix for manufacturer and physician partnerships.

Others

• McKesson: Largest US pharmaceutical wholesaler; competes with Healix's wholesale distribution arm and also operates US Oncology Network infusion services, providing both supply-side and downstream infusion exposure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/HealixHealth
• Facebookfacebook.com/HealixInc
• LinkedInlinkedin.com/company/healix

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healix